Siste oppdatering :
19/11/2024
Infostab
Lister
Sammendrag
Søk etter kompatibilitet
Y-side kompatibilitetstabell
Referanser
Forskerteamet
valistab
plakat
Tilkoblinger
sponsorer
Forfatter
Instruksjon
Nyhetsbrev
Referanser 4569
Type :
Journal
Internett-koblingen :
https://doi.org/10.1177/0018578719893376
Forskerteamet :
La Crosse - Department of Medical Education, Gundersen HealthSystem, La Crosse, USA
Forfattere :
Lee T.M , Villareal C.L, Meyer L.M.
Tittel :
Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
Nummer :
Hosp Pharm ; 56, 4: 282-286. 2021
Nivå of Evidence :
fysisk stabilitet :
kjemisk stabilitet :
andre metoder :
Kommentarer :
Lister
Cisatracurium besylate
1 mg/ml
+
Levetiracetam
5 mg/ml
+
Dexmedetomidine
4 µg/ml
+
Levetiracetam
5 mg/ml
+
Fosphenytoin sodium
15 mg/ml
+
Levetiracetam
5 mg/ml
+
Levetiracetam
5 mg/ml
+
Cisatracurium besylate
1 mg/ml
+
5 mg/ml
+
Dexmedetomidine
4 µg/ml
+
5 mg/ml
+
Fosphenytoin sodium
15 mg/ml
+
5 mg/ml
+
Norepinephrine bitartrate
0,016 >>0,064 mg/ml
+
5 mg/ml
+
Piperacillin sodium / tazobactam
45 mg/ml
+
5 mg/ml
+
Piperacillin sodium / tazobactam
33,75 mg/ml
+
5 mg/ml
+
Propofol
10 mg/ml
+
5 mg/ml
+
Vancomycin hydrochloride
5 mg/ml
+
5 mg/ml
+
Vasopressin
1 UI/ml
+
Norepinephrine bitartrate
0,016 >>0,064 mg/ml
+
Levetiracetam
5 mg/ml
+
Piperacillin sodium / tazobactam
45 mg/ml
+
Levetiracetam
5 mg/ml
+
33,75 mg/ml
+
Levetiracetam
5 mg/ml
+
Propofol
10 mg/ml
+
Levetiracetam
5 mg/ml
+
Vancomycin hydrochloride
5 mg/ml
+
Levetiracetam
5 mg/ml
+
Vasopressin
1 UI/ml
+
Levetiracetam
5 mg/ml
+
Mentions Légales
